The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Leukapheresis Market Research Report 2024

Global Leukapheresis Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1417211

No of Pages : 75

Synopsis

Leukapheresis is a laboratory procedure in which white blood cells are separated from a sample of blood. It is a specific type of apheresis, the more general term for separating out one particular constituent of blood and returning the remainder to the circulation.

The global Leukapheresis market was valued at US$ 53 million in 2023 and is anticipated to reach US$ 92 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.

North American market for Leukapheresis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Leukapheresis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Leukapheresis in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Leukapheresis include Asahi Kasei Medical, Fresenius, Haemonetics, Hemacare Corporation, Terumo BCT, Stemcell Technologies and Bioivt, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Leukapheresis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leukapheresis.

Report Scope

The Leukapheresis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Leukapheresis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Leukapheresis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company (Partial List)

  • Asahi Kasei Medical
  • Fresenius
  • Haemonetics
  • Hemacare Corporation
  • Terumo BCT
  • Stemcell Technologies
  • Bioivt

Segment by Type

  • Leukapheresis Devices
  • Leukapheresis Disposables

Segment by Application

  • Hospitals
  • Research Institute

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Leukapheresis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukapheresis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Leukapheresis Devices
1.2.3 Leukapheresis Disposables
1.3 Market by Application
1.3.1 Global Leukapheresis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Research Institute
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Leukapheresis Market Perspective (2019-2030)
2.2 Leukapheresis Growth Trends by Region
2.2.1 Global Leukapheresis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Leukapheresis Historic Market Size by Region (2019-2024)
2.2.3 Leukapheresis Forecasted Market Size by Region (2025-2030)
2.3 Leukapheresis Market Dynamics
2.3.1 Leukapheresis Industry Trends
2.3.2 Leukapheresis Market Drivers
2.3.3 Leukapheresis Market Challenges
2.3.4 Leukapheresis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Leukapheresis Players by Revenue
3.1.1 Global Top Leukapheresis Players by Revenue (2019-2024)
3.1.2 Global Leukapheresis Revenue Market Share by Players (2019-2024)
3.2 Global Leukapheresis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Leukapheresis Revenue
3.4 Global Leukapheresis Market Concentration Ratio
3.4.1 Global Leukapheresis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukapheresis Revenue in 2023
3.5 Leukapheresis Key Players Head office and Area Served
3.6 Key Players Leukapheresis Product Solution and Service
3.7 Date of Enter into Leukapheresis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Leukapheresis Breakdown Data by Type
4.1 Global Leukapheresis Historic Market Size by Type (2019-2024)
4.2 Global Leukapheresis Forecasted Market Size by Type (2025-2030)
5 Leukapheresis Breakdown Data by Application
5.1 Global Leukapheresis Historic Market Size by Application (2019-2024)
5.2 Global Leukapheresis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Leukapheresis Market Size (2019-2030)
6.2 North America Leukapheresis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Leukapheresis Market Size by Country (2019-2024)
6.4 North America Leukapheresis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Leukapheresis Market Size (2019-2030)
7.2 Europe Leukapheresis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Leukapheresis Market Size by Country (2019-2024)
7.4 Europe Leukapheresis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Leukapheresis Market Size (2019-2030)
8.2 Asia-Pacific Leukapheresis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Leukapheresis Market Size by Region (2019-2024)
8.4 Asia-Pacific Leukapheresis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Leukapheresis Market Size (2019-2030)
9.2 Latin America Leukapheresis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Leukapheresis Market Size by Country (2019-2024)
9.4 Latin America Leukapheresis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Leukapheresis Market Size (2019-2030)
10.2 Middle East & Africa Leukapheresis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Leukapheresis Market Size by Country (2019-2024)
10.4 Middle East & Africa Leukapheresis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Asahi Kasei Medical
11.1.1 Asahi Kasei Medical Company Detail
11.1.2 Asahi Kasei Medical Business Overview
11.1.3 Asahi Kasei Medical Leukapheresis Introduction
11.1.4 Asahi Kasei Medical Revenue in Leukapheresis Business (2019-2024)
11.1.5 Asahi Kasei Medical Recent Development
11.2 Fresenius
11.2.1 Fresenius Company Detail
11.2.2 Fresenius Business Overview
11.2.3 Fresenius Leukapheresis Introduction
11.2.4 Fresenius Revenue in Leukapheresis Business (2019-2024)
11.2.5 Fresenius Recent Development
11.3 Haemonetics
11.3.1 Haemonetics Company Detail
11.3.2 Haemonetics Business Overview
11.3.3 Haemonetics Leukapheresis Introduction
11.3.4 Haemonetics Revenue in Leukapheresis Business (2019-2024)
11.3.5 Haemonetics Recent Development
11.4 Hemacare Corporation
11.4.1 Hemacare Corporation Company Detail
11.4.2 Hemacare Corporation Business Overview
11.4.3 Hemacare Corporation Leukapheresis Introduction
11.4.4 Hemacare Corporation Revenue in Leukapheresis Business (2019-2024)
11.4.5 Hemacare Corporation Recent Development
11.5 Terumo BCT
11.5.1 Terumo BCT Company Detail
11.5.2 Terumo BCT Business Overview
11.5.3 Terumo BCT Leukapheresis Introduction
11.5.4 Terumo BCT Revenue in Leukapheresis Business (2019-2024)
11.5.5 Terumo BCT Recent Development
11.6 Stemcell Technologies
11.6.1 Stemcell Technologies Company Detail
11.6.2 Stemcell Technologies Business Overview
11.6.3 Stemcell Technologies Leukapheresis Introduction
11.6.4 Stemcell Technologies Revenue in Leukapheresis Business (2019-2024)
11.6.5 Stemcell Technologies Recent Development
11.7 Bioivt
11.7.1 Bioivt Company Detail
11.7.2 Bioivt Business Overview
11.7.3 Bioivt Leukapheresis Introduction
11.7.4 Bioivt Revenue in Leukapheresis Business (2019-2024)
11.7.5 Bioivt Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’